Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with epithelial ovarian cancer

Killer immunoglobulin-like receptors (KIRs) regulate function of NK cells and subsets of T cells. HLA class I molecules are ligands for inhibitory KIRs while specificity of activating KIRs is mainly unknown. Both KIR and HLA genotypes are highly polymorphic. In this study we analyzed associations of KIR and KIR ligand genes with the incidence and clinical course of epithelial ovarian cancer. DNA of 142 patients was analyzed for KIR genes and 103 samples were typed for HLA class I. Control group consisted of 200 healthy individuals, including 83 women, analyzed separately. The frequency of KIR genes in patients and controls were comparable. HLA-C group 1 (ligand for KIR2DL2/3) was more frequent in patients than in controls (86.4% vs. 67.5%, p = 0.002). The frequency of KIR2DS4f1 was higher in patients with endometrioid cancer (72.3%) compared with other histological subtypes (36.5%, p = 0.004) and controls (29.5%, p = 0.0001). KIR and KIR ligand genotype did not influence significantly the clinical course of the disease. We conclude that the genotype of KIR ligands is strongly associated with the incidence of epithelial ovarian cancer while KIR2DS4f1 confers susceptibility to endometrioid subtype of the disease. (c) 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.